Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Istvan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Epidemiology and Psychiatric Sciences|September 19, 2023
Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance dataEdouard-Jules Laforgue, Marion Istvan, Anicet Chaslerie, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Poppers Use and High Methaemoglobinaemia: 'Dangerous Liaisons'Malcolm Barrangou-Poueys-Darlas, Marie Gerardin, Sylvie Deheul, et al.
BMJ Open|October 1, 2018
What is the evolution of stroke unit's accessibility in metropolitan France from 2009 to 2014? A trend analysis of over 600 000 patients using national hospital databasesMarion Istvan, Camille Lecoffre, Sahar Bayat, et al.
European Journal of Public Health|February 7, 2023
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory changeAurélie Aquizerate, Edouard-Jules Laforgue, Marion Istvan, et al.
British Journal of Clinical Pharmacology|January 28, 2021
Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO studyMarion Istvan, Pascal Caillet, Morgane Rousselet, et al.
Frontiers in Public Health|May 19, 2023
Nitrous oxide: a unique official French addictovigilance national surveyMarylène Guerlais, Aurélie Aquizerate, Arthur Lionnet, et al.
Expert Opinion on Drug Safety|June 4, 2021
What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance databaseEdouard-Jules Laforgue, Marion Istvan, Marylène Guerlais, et al.
Drug Metabolism Reviews|December 16, 2020
CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessationMalcolm Barrangou-Poueys-Darlas, Marylène Guerlais, Edouard-Jules Laforgue, et al.
Harm Reduction Journal|March 29, 2023
First results of the French OCTOPUS survey among festival attendees: a latent class analysisMarion Istvan, Vincent Bresdin, Marie Mainguy, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Epidemiology and Psychiatric Sciences|September 19, 2023
Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance dataEdouard-Jules Laforgue, Marion Istvan, Anicet Chaslerie, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Poppers Use and High Methaemoglobinaemia: 'Dangerous Liaisons'Malcolm Barrangou-Poueys-Darlas, Marie Gerardin, Sylvie Deheul, et al.
BMJ Open|October 1, 2018
What is the evolution of stroke unit's accessibility in metropolitan France from 2009 to 2014? A trend analysis of over 600 000 patients using national hospital databasesMarion Istvan, Camille Lecoffre, Sahar Bayat, et al.
European Journal of Public Health|February 7, 2023
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory changeAurélie Aquizerate, Edouard-Jules Laforgue, Marion Istvan, et al.
British Journal of Clinical Pharmacology|January 28, 2021
Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO studyMarion Istvan, Pascal Caillet, Morgane Rousselet, et al.
Frontiers in Public Health|May 19, 2023
Nitrous oxide: a unique official French addictovigilance national surveyMarylène Guerlais, Aurélie Aquizerate, Arthur Lionnet, et al.
Expert Opinion on Drug Safety|June 4, 2021
What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance databaseEdouard-Jules Laforgue, Marion Istvan, Marylène Guerlais, et al.
Drug Metabolism Reviews|December 16, 2020
CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessationMalcolm Barrangou-Poueys-Darlas, Marylène Guerlais, Edouard-Jules Laforgue, et al.
Harm Reduction Journal|March 29, 2023
First results of the French OCTOPUS survey among festival attendees: a latent class analysisMarion Istvan, Vincent Bresdin, Marie Mainguy, et al.
Pageof 2